HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of 5-vinyl-1-beta-D-arabinofuranosyluracil (VaraU) against herpes simplex virus type 2 strains in cell cultures and against experimental herpes encephalitis in mice: comparison with acyclovir and foscarnet.

Abstract
The sensitivity of different herpes simplex virus type 2 (HSV-2) strains to inhibition by 5-vinyl-1-beta-D-arabinofuranosyluracil (VaraU) was evaluated in comparison to 9-(2-hydroxyethoxymethyl)guanine (ACV; acyclovir) and trisodiumphosphonoformate (Na3PFA; foscarnet), using a plaque inhibition assay in primary rabbit testes (PRT) cells as well as in human embryonic lung fibroblast (HELF) cell cultures. The order of decreasing activity found was ACV much greater than VaraU greater than Na3PFA in PRT cells and ACV greater than VaraU much greater than Na3PFA in HELF cells, with 50% inhibition doses (ID50) of 1.8, 8.8, and greater than 110 microM for the three drugs in HELF cells, respectively. After 72hr of drug treatment, inhibition of HELF cell proliferation by VaraU (ID50, greater than 1000 microM) was less than that by ACV and Na3PFA, resulting in high selectivity indexes of greater than 100 against HSV-2 for VaraU and ACV. Their in vivo efficacy was assessed in a mouse encephalitis model. Using a treatment schedule of three daily intraperitoneal (ip) doses over a period of 5 days, only the survival times of mice were considerably prolonged by VaraU (150 or 300 mg/kg per day; P less than 0.05 or P less than 0.001, respectively). In contrast, ACV treatment (150 mg/kg per day) led to a nearly complete prevention of encephalitis and death (P less than 0.001). Similar therapy results with VaraU application through the drinking water were obtained using only one-sixth of the high ip dose (approximately 50 mg/kg per day) but over a prolonged period of treatment. Under similar conditions no therapeutic effect of oral Na3PFA was observed.
AuthorsJ Reefschläger, P Wutzler, K D Thiel, G Herrmann
JournalPharmaceutical research (Pharm Res) Vol. 4 Issue 3 Pg. 200-6 (Jun 1987) ISSN: 0724-8741 [Print] United States
PMID2855541 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Antiviral Agents
  • Organophosphorus Compounds
  • Arabinofuranosyluracil
  • Foscarnet
  • 5-vinyl-1-arabinofuranosyluracil
  • Phosphonoacetic Acid
  • Uridine
  • Acyclovir
Topics
  • Acyclovir (pharmacology)
  • Animals
  • Antiviral Agents (pharmacology)
  • Arabinofuranosyluracil (analogs & derivatives, pharmacology)
  • Cells, Cultured
  • Encephalitis (drug therapy, microbiology)
  • Female
  • Foscarnet
  • Herpes Simplex (drug therapy)
  • Mice
  • Organophosphorus Compounds (pharmacology)
  • Phosphonoacetic Acid (analogs & derivatives, pharmacology)
  • Simplexvirus (drug effects)
  • Uridine (analogs & derivatives)
  • Virus Replication (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: